Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent…
New York, May 16, 2024 /PRNewswire/ -- Selous Therapeutics (NASDAQ:), Inc. (Nasdaq: SEEL) (“Seelos” or the “Company”), a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system (“CNS”)…
